Clinical Trial

Global Healthcare Study on Atopic Dermatitis

Study acronym: GHSAD
Recruiting
View on ClinicalTrials.gov →
Summary
The Global Healthcare Study on Atopic Dermatitis (GHSAD) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with atopic dermatitis. The study collects standardized clinical data from routine medical records to identify disparities in healthcare delivery and outcomes across different healthcare systems.
Trial Details
NCT Number NCT07659756
Lead Sponsor Julia Tatjana Maul
Collaborators: University of Zurich, University Hospital, Zürich
Conditions Atopic Dermatitis (AD), Atopic Dermatitis (Eczema)
Enrollment 9,600 participants
Start Date 2025-01-01
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-22